Back to discover
Disease
Emergencies
Late-stage therapeutic developmentEmerging research
1
Publications
18
Clinical trials
2020
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
Mental health outcomes of the CoViD-19 pandemic.
Research2020-05-01Rivista di psichiatria
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Executive briefingUpdating summary…Momentum: Low
Key developments
- 3 clinical trials expected to report results, the earliest in Q1 2027.
- 1 industry development reported.
Upcoming Milestones
- Q1 2027INDICIA: Evolution of the Initial Distribution Volume of Glucose in the Severe Burned Adults
- Q2 2027Nebulized Fentanyl in Healthy Volunteers : Comparison of Facial Versus Intranasal Aerosol Administration by Pharmacometric Modeling
- Q3 2031Laparoscopic Approach for Emergency Colon Resection: a Randomized Controlled Trial
Major developments
Major clinical milestoneHigh impact
Primary completion2026-09-01
Upcoming trial readoutImportant
Results expected Q2 20272026-05-11
Clinical MilestonesViewHide
Results expected
- 2026-05-11Nebulized Fentanyl in Healthy Volunteers : Comparison of Facial Versus Intranasal Aerosol Administration by Pharmacometric ModelingResults expected Q2 2027
- 2026-04-22Laparoscopic Approach for Emergency Colon Resection: a Randomized Controlled TrialResults expected Q3 2031
- 2026-03-12INDICIA: Evolution of the Initial Distribution Volume of Glucose in the Severe Burned AdultsResults expected Q1 2027
Recently completed
- 2026-09-01Evaluation of the Effects of Ketorolac 15mg IV Versus 30mg IV on Duration of Analgesia in Patients Who Present to the Emergency Department With Renal ColicPrimary completion
- 2026-04-01A Randomized Comparative Prospective Multicenter Study of the Efficacy of a Systematic Referral to Palliative Care of Patients Who Need for Palliative Care During an Unscheduled Visit in Comprehensive Anticancer CentersPrimary completion
Industry & MarketViewHide
- 2026-09-09Phone-call tutorials improve learning cost-effectively during education emergenciesIndustry · Nature News
Activity timeline6
- 2026-09-09IndustryPhone-call tutorials improve learning cost-effectively during education emergenciesIndustry · Nature News
- 2026-09-01ClinicalEvaluation of the Effects of Ketorolac 15mg IV Versus 30mg IV on Duration of Analgesia in Patients Who Present to the Emergency Department With Renal ColicPrimary completion
- 2026-05-11ClinicalNebulized Fentanyl in Healthy Volunteers : Comparison of Facial Versus Intranasal Aerosol Administration by Pharmacometric ModelingResults expected Q2 2027
- 2026-04-22ClinicalLaparoscopic Approach for Emergency Colon Resection: a Randomized Controlled TrialResults expected Q3 2031
- 2026-04-01ClinicalA Randomized Comparative Prospective Multicenter Study of the Efficacy of a Systematic Referral to Palliative Care of Patients Who Need for Palliative Care During an Unscheduled Visit in Comprehensive Anticancer CentersPrimary completion
- 2026-03-12ClinicalINDICIA: Evolution of the Initial Distribution Volume of Glucose in the Severe Burned AdultsResults expected Q1 2027
Clinical trials
The current development programme across all trial phases.
Clinical programme
18
6
8
6
Late-stage studies
Recruiting
Recently completed
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Most influential
Recent publications
Major themes1
- Betacoronavirus1
Leading journals1
- Rivista di psichiatria1
Leading researchers8
- Capelli F1
- Carai M1
- Carnaghi G1
- di Bernardo A1
- Faleri S1
- Pacitti F1
- Socci V1
- Talevi D1
Affiliations (unnormalised)2
- Department of Biotechnological and Applied Clinical Sciences1
- Sapienza University of Rome.1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
Situations or conditions requiring immediate intervention to avoid serious adverse results.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.